iPharma Retatrutide 30mg Pre-Filled Pen

Next-Generation Metabolic Research Advanced Triple-Action Peptide

Retatrutide is a triple-action receptor agonist researched for its interaction with GIP, GLP-1, and glucagon receptors. Supplied in a convenient 30mg pen format, Retatrutide represents one of the latest advancements in metabolic and wellness-focused peptide research.

By combining three metabolic pathways into a single formulation, Retatrutide has gained significant attention in studies involving appetite regulation, energy balance, and metabolic wellness support.

Features & Benefits

30mg Retatrutide peptide formulation

Convenient injectable pen format

Triple-action GIP, GLP-1, and glucagon receptor research

Investigated for metabolic wellness pathways

Research interest in appetite and satiety support

Studied for energy-expenditure and metabolic regulation pathways

Associated with blood sugar and metabolic-balance research

Widely recognised in advanced metabolic investigations

How Retatrutide Works

Retatrutide is researched for its interaction with:

GIP receptors

GLP-1 receptors

Glucagon receptors

By adding glucagon receptor activity to the established GIP/GLP-1 pathway approach, Retatrutide is studied for its potential role in both appetite control and energy-expenditure support.

Early investigational studies have shown promising findings in metabolic and wellness-related research environments.

Handling & Use

For research use only.

Handle using sterile laboratory procedures.

Store according to packaging instructions.

Use only in controlled research environments.

Important Information

Not approved for human consumption.

Not intended for therapeutic or medical use.

This product is supplied strictly for research purposes only.